about
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.Expression of AR-V7 and ARv567es in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in TAXYNERGYSubstrate mediated interaction between pairs of keratocytes: Multipole traction force models describe their migratory behaviorSmall-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.Using circulating tumor cells to advance precision medicine in prostate cancerAndrogen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients
P50
description
researcher
@en
name
Daniel Worroll
@en
type
label
Daniel Worroll
@en
prefLabel
Daniel Worroll
@en
P31
P496
0000-0001-7351-676X